219 related articles for article (PubMed ID: 19042203)
1. Medical consequences of drug abuse and co-occurring infections: research at the National Institute on Drug Abuse.
Khalsa JH; Treisman G; McCance-Katz E; Tedaldi E
Subst Abus; 2008; 29(3):5-16. PubMed ID: 19042203
[TBL] [Abstract][Full Text] [Related]
2. Drug interactions between antiretroviral medications and medications used in the treatment of drug addiction: research needs.
Khalsa JH; Elkashef A
Am J Addict; 2010; 19(1):96-100. PubMed ID: 20132126
[TBL] [Abstract][Full Text] [Related]
3. Clinical management of drug addicts infected with human immunodeficiency virus and hepatitis C virus.
Khalsa JH; Vocci F
J Addict Dis; 2008; 27(2):1-10. PubMed ID: 18681186
[TBL] [Abstract][Full Text] [Related]
4. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs.
Altice FL; Kamarulzaman A; Soriano VV; Schechter M; Friedland GH
Lancet; 2010 Jul; 376(9738):367-87. PubMed ID: 20650518
[TBL] [Abstract][Full Text] [Related]
5. Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses.
Neuman MG; Monteiro M; Rehm J
Subst Use Misuse; 2006; 41(10-12):1395-463. PubMed ID: 17002989
[TBL] [Abstract][Full Text] [Related]
6. Drug-Drug Interactions and Diagnostics for Drug Users With HIV and HIV/HCV Coinfections: Introduction.
Khalsa JH; Talal AH; Morse G
Clin Pharmacol Drug Dev; 2017 Mar; 6(2):108-117. PubMed ID: 28263456
[TBL] [Abstract][Full Text] [Related]
7. Interventions for HIV and hepatitis C virus infections in recreational drug users.
Khalsa JH; Elkashef A
Clin Infect Dis; 2010 Jun; 50(11):1505-11. PubMed ID: 20415569
[TBL] [Abstract][Full Text] [Related]
8. Perspectives on HIV/hepatitis C virus co-infection, illicit drug use and mental illness.
Sulkowski MS; Thomas DL
AIDS; 2005 Oct; 19 Suppl 3():S8-12. PubMed ID: 16251833
[No Abstract] [Full Text] [Related]
9. Schizophrenia and comorbid human immunodeficiency virus or hepatitis C virus.
Cournos F; McKinnon K; Sullivan G
J Clin Psychiatry; 2005; 66 Suppl 6():27-33. PubMed ID: 16107181
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C and HIV Coinfection for Social Workers in Public Health, Medical and Substance Use Treatment Settings.
Sims OT; Womack BG
Soc Work Public Health; 2015; 30(4):325-35. PubMed ID: 25811121
[TBL] [Abstract][Full Text] [Related]
11. Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir: Drug Interactions With Antiretroviral Agents and Drugs forSubstance Abuse.
King JR; Menon RM
Clin Pharmacol Drug Dev; 2017 Mar; 6(2):201-205. PubMed ID: 28263457
[TBL] [Abstract][Full Text] [Related]
12. Medical illness and comorbidities in drug users: implications for addiction pharmacotherapy treatment.
Draper JC; McCance-Katz EF
Subst Use Misuse; 2005; 40(13-14):1899-921, 2043-8. PubMed ID: 16282085
[TBL] [Abstract][Full Text] [Related]
13. Should the reorganization of addiction-related research across all the National Institutes of Health be structural?--The devil is truly in the details.
Johnson BA; Messing RO; Charness ME; Crabbe JC; Goldman MS; Harris RA; Kranzler HR; Mitchell MC; Nixon SJ; Riley EP; Schuckit MA; Sher KJ; Thomas JD
Alcohol Clin Exp Res; 2011 Apr; 35(4):572-80. PubMed ID: 21443646
[TBL] [Abstract][Full Text] [Related]
14. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.
Roux P; Fugon L; Winnock M; Salmon-Céron D; Lacombe K; Sogni P; Spire B; Dabis F; Carrieri MP;
Addiction; 2012 Jan; 107(1):152-9. PubMed ID: 21819472
[TBL] [Abstract][Full Text] [Related]
15. Medical management of HIV-hepatitis C virus coinfection in injection drug users.
Khalsa JH; Kresina T; Sherman K; Vocci F
Clin Infect Dis; 2005 Jul; 41 Suppl 1():S1-6. PubMed ID: 16265605
[TBL] [Abstract][Full Text] [Related]
16. Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinic.
Gelkopf M; Weizman T; Melamed Y; Adelson M; Bleich A
Isr J Psychiatry Relat Sci; 2006; 43(2):126-36. PubMed ID: 16910375
[TBL] [Abstract][Full Text] [Related]
17. Impact of HIV and chronic kidney disease comorbidities on hepatitis C treatment choices, drug-drug interactions and hepatitis C cure.
Ali S; Ur-Rehman T; Lougher E; Mutimer D; Ali M; Paudyal V
Int J Clin Pharm; 2020 Apr; 42(2):515-526. PubMed ID: 32100238
[TBL] [Abstract][Full Text] [Related]
18. Recognition of hepatitis C virus coinfection in HIV-positive injecting drug users in Asia.
Walsh N; Higgs P; Crofts N
J Acquir Immune Defic Syndr; 2007 Jul; 45(3):363-5. PubMed ID: 17592339
[No Abstract] [Full Text] [Related]
19. Psychiatric implications of hepatitis-C infection.
Giunta B; Somboonwit C; Nikolic WV; Rrapo E; Tan J; Shapshak P; Fernandez F
Crit Rev Neurobiol; 2007; 19(2-3):79-118. PubMed ID: 19409058
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus and hepatitis C virus co-infection.
Vlahakis SR
J Med Liban; 2006; 54(2):106-10. PubMed ID: 17087002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
